Guggenheim Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $63.58 +1.15%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 45
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 45
Join SI Premium – FREE
Guggenheim analyst Seamus Fernandez upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Neutral to Buy with a price target of $62.00.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $51.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
- William Blair Downgrades Lifecore Biomedical (LFCR) to Market Perform
- Lightspeed POS Inc. (LSPD)Assumed at Equalweight at Morgan Stanley
Create E-mail Alert Related Categories
UpgradesRelated Entities
Maynard Um, Guggenheim, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
